Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-16

FDA Approved: MICAFUNGIN — Original Application (Par Health USA, LLC)

View source ↗

Summary

FDA approved a micafungin product via an original NDA submitted by Par Health USA, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micafungin (micafungin)

Snippet

ORIG AP for MICAFUNGIN (MICAFUNGIN)